{"id":5921,"date":"2019-12-03T15:08:31","date_gmt":"2019-12-03T14:08:31","guid":{"rendered":"http:\/\/wordpress.p545550.webspaceconfig.de\/uncategorized\/immunic-ernennt-neuen-chief-financial-officer\/"},"modified":"2020-06-25T11:57:58","modified_gmt":"2020-06-25T09:57:58","slug":"immunic-ernennt-neuen-chief-financial-officer","status":"publish","type":"post","link":"https:\/\/www.izb-online.de\/en\/immunic-ernennt-neuen-chief-financial-officer\/","title":{"rendered":"Immunic appoints new Chief Financial Officer"},"content":{"rendered":"

[vc_row el_class=”gco-magazine-container”][vc_column el_class=”bildspalte”][vc_row_inner][vc_column_inner offset=”vc_col-lg-12 vc_col-md-12″][vc_column_text el_class=”gco-magazine–title”]<\/p>\n

Immunic appoints new Chief Financial Officer <\/span><\/h1>\n

[\/vc_column_text][vc_column_text el_class=”gco-magazine–post-date”]December 2019[\/vc_column_text][\/vc_column_inner][\/vc_row_inner][vc_row_inner el_class=”gco-magazine-container–copy”][vc_column_inner][vc_column_text]Immunic, Inc., a clinical-stage biopharmaceutical company focused on developing potentially best-in-class, oral therapies for the treatment of chronic inflammatory and autoimmune diseases, announced the appointment of Sanjay S. Patel, CFA, as Chief Financial Officer, effective July 15, 2019. Sanjay Patel replaces Tamara A. Seymour, who has served as the company\u2019s Interim Chief Financial Officer since April 2019. \u201cWith a deep well of C-Suite and investment banking experience, Sanjay\u2019s proven track record, strong knowledge base and established industry relationships will be especially important to us,\u201d stated Daniel Vitt, PhD, Chief Executive Officer and President of Immunic. From 2014 to 2016 Patel served as Chief Financial Officer of Pernix Therapeutics Holdings, Inc. He was Managing Director, Healthcare Investment Banking at Cantor Fitzgerald from 2009 \u00adto 2014.
\n[\/vc_column_text][vc_column_text css=”.vc_custom_1583761043671{background-color: #1e73be !important;}” el_class=”redaktionell”][\/vc_column_text][\/vc_column_inner][\/vc_row_inner][vc_row_inner el_class=”gco-magazine–quote”][vc_column_inner][vc_single_image image=”5919″ img_size=”155×155″ alignment=”center” style=”vc_box_circle_2″][vc_column_text el_class=”gco-magazine–picture-discription-blank”]Sanjay S. Patel<\/strong>,
\nCFO, Immunic[\/vc_column_text][vc_column_text el_class=”gco-magazine-copyright-blank”]<\/p>\n

\u00a9 Immunic<\/p>\n

[\/vc_column_text][\/vc_column_inner][\/vc_row_inner][vc_row_inner css=”.vc_custom_1592823764249{margin-top: 45px !important;}”][vc_column_inner]\n\n

\n \n